Every SEC Form 3/4/5 on record for this filer (CIK 1236514) — 4 issuers, 76 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | Director | 2018-02-27 → 2026-06-15 | 16 | −$456,623 |
| RIGL | RIGEL PHARMACEUTICALS INC | Director | 2026-02-03 → 2026-05-19 | 3 | — |
| BTAI | BioXcel Therapeutics, Inc. | Director | 2022-07-05 → 2026-01-12 | 5 | — |
| JAZZ | Jazz Pharmaceuticals plc | EVP, US Commercial · lapsed | 2015-09-29 → 2020-03-13 | 56 | −$2M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PBYI | 2025-11-11 | Sell | 20,000 | $4.86 | $97,200 | 54,000 |
| PBYI | 2024-08-12 | Sell | 23,358 | $3.49 | $81,519 | 47,000 |
| PBYI | 2023-11-07 | Sell | 25,000 | $2.83 | $70,750 | 43,358 |
| PBYI | 2023-06-13 | Sell | 13,500 | $3.45 | $46,575 | 41,358 |
| PBYI | 2022-08-09 | Sell | 25,000 | $3.55 | $88,750 | 54,858 |
4 of 4 issuers are covered and open a security page; the rest are on file here only.
